CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited
Your view on CSPCY
Overview
What the company does, where it operates, and who runs it.
About CSPC Pharmaceutical Group Limited
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
- CEO
- Lei Cai
- Headquarters
- No. 226 Huanghe Street, Shijiazhuang, CN
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
- CEO
- Lei Cai
- Headquarters
- No. 226 Huanghe Street, Shijiazhuang, CN
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally.
The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.
The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries.
In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013.
CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for CSPC Pharmaceutical Group Limited, and the rating behind it. CSPCY last traded at $5.05, 11.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for CSPC Pharmaceutical Group Limited. Starting points for CSPC Pharmaceutical Group Limited: P/E 11.5, EPS $2.57, beta 0.91 — an Drug Manufacturers - General name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for CSPC Pharmaceutical Group Limited. CSPC Pharmaceutical Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for CSPC Pharmaceutical Group Limited. Trailing twelve-month EPS for CSPC Pharmaceutical Group Limited stands at $2.57. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for CSPC Pharmaceutical Group Limited. CSPC Pharmaceutical Group Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
CSPC Pharmaceutical Group Limited valued side by side against its closest peers. CSPC Pharmaceutical Group Limited is measured against Drug Manufacturers - General peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold CSPC Pharmaceutical Group Limited, and how their positions are changing. At a $14.59B market value, institutional positions materially move CSPC Pharmaceutical Group Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by CSPC Pharmaceutical Group Limited executives and directors. Shares of CSPC Pharmaceutical Group Limited have traded between $2.31 and $5.83 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming CSPC Pharmaceutical Group Limited. CSPC Pharmaceutical Group Limited is a $14.59B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming CSPC Pharmaceutical Group Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for CSPC Pharmaceutical Group Limited. Coverage tracks CSPC Pharmaceutical Group Limited within Drug Manufacturers - General (Healthcare). Press releases and market coverage, newest first.